Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04392375 · ClinicalTrials.gov registry record · Phase 4
Nifedipine XL Versus Placebo for the Treatment of Preeclampsia With Severe Features During Induction of Labor
A Phase 4 study, sponsored by Ohio State University.
- Completed
- Registry status
- Phase 4
- Development phase
- 110
- Enrollment target
NCT04392375 is a Phase 4 study that has completed, run by Ohio State University. The registered enrollment target is 110 participants.
The verdict
NCT04392375, a Phase 4 study, has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 110 participants
- Enrollment target
Study Summary
This is a randomized double blind placebo controlled trial comparing Nifedipine 30mg XL to placebo in 110 patients after decision has been made to proceed with induction of labor for the diagnosis of preeclampsia with severe features.
Interventions
- DRUG Placebos
- DRUG Nifedipine 30 MG
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2020-06-09 |
| Est. Completion | 2022-05-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04392375
The ClinicalTrials.gov registry entry for NCT04392375 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebos is the first listed.
NCT04392375 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04392375 about?
NCT04392375 is a clinical study titled "Nifedipine XL Versus Placebo for the Treatment of Preeclampsia With Severe Features During Induction of Labor". This is a randomized double blind placebo controlled trial comparing Nifedipine 30mg XL to placebo in 110 patients after decision has been made to proceed with induction of labor for the diagnosis of preeclampsia with severe features.
What is the current status of trial NCT04392375?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 110 participants. The study started on 2020-06-09. Estimated completion is 2022-05-10.
What interventions are being tested in trial NCT04392375?
The interventions under investigation include: Placebos (DRUG), Nifedipine 30 MG (DRUG).
Who is sponsoring clinical trial NCT04392375?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.